Yahoo奇摩 網頁搜尋

搜尋結果

  1. 2021年10月29日 · TOKYO (Reuters) -Takeda Pharmaceutical Co, the Japanese partner for Novavax Inc's COVID-19 vaccine, is preparing to seek regulatory approval for a roll out in Japan early next ...

  2. 2021年9月8日 · Participants will receive a combination of the company's COVID-19 vaccine candidate, NVX-CoV2373, and its Influenza shot NanoFlu along with an adjuvant or vaccine booster.

  3. 2020年8月7日 · Japan plans to buy AstraZeneca Plc's experimental COVID-19 vaccine and fund a local company to manufacture Novavax's vaccine candidate, ramping up its stockpile plan as it battles surging infections.

  4. 2022年2月3日 · BERLIN (Reuters) -Germany's expert panel on vaccine use on Thursday recommended Novavax's protein-based COVID-19 vaccine for basic immunisation for people over 18, in a push to win over the more ...

  5. 2022年7月19日 · U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday.

  6. 2021年11月1日 · (Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its chief executive told Reuters, after ...

  7. 2021年1月20日 · South Korea is in talks to purchase 40 million doses of a coronavirus vaccine developed by Novavax, its local manufacturer SK bioscience said on Wednesday. The deal, if agreed ...